These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 4614295)

  • 41. [Reduction of fresh forms of pulmonary tuberculosis by the classical treatment and by combined antibiotics including rifampicin (comparative study of a personal survey)].
    Weill G; Lévy A; Guignon JP; Lecoq H; Friess JM; Maman P
    Rev Tuberc Pneumol (Paris); 1969 Dec; 33(8):1119-25. PubMed ID: 4916253
    [No Abstract]   [Full Text] [Related]  

  • 42. [Short-term chemotherapy of pulmonary tuberculosis. Pilot study].
    Poppe de Figueiredo F; Brito AA; Laborne Valle JH; Tavares PM; Trannin PL
    Bull Int Union Tuberc; 1974; 49(1):411-7. PubMed ID: 4619561
    [No Abstract]   [Full Text] [Related]  

  • 43. [Double antibacterial therapy in untreated tuberculosis. Retrospective study of 120 unselected patients treated between 1972 and 1974].
    Augé C; Lecocguic Y; Touaty E; Bussi S; Pariente R
    Rev Fr Mal Respir; 1982; 10(6):391-9. PubMed ID: 6819611
    [No Abstract]   [Full Text] [Related]  

  • 44. [Daily and intermittent regimens using ethambutol and rifampicin in the treatment of unresponsive cases. (Evaluation after 1 year.) II. Side effects].
    Girling DJ
    Bull Int Union Tuberc; 1974; 49(1):451-5. PubMed ID: 4619567
    [No Abstract]   [Full Text] [Related]  

  • 45. [Treatment of chronic tuberculosis with ethambutol and prothionamide associated with rifomycin of capreomycin].
    Grassi C
    Acta Tuberc Pneumol Belg; 1969; 60(3):450-4. PubMed ID: 4906991
    [No Abstract]   [Full Text] [Related]  

  • 46. [Retreatment of tuberculosis resistent to 1st and 2d line drugs with AMP rifomycin and ethambutol].
    Ibarra JP; Pińeyro J; Mello Aguerre M; Pintos Fuentes R; Trenchi A; Freijeiro R; Bazerque E
    Hoja Tisiol; 1970; 27(1):98-117. PubMed ID: 5524669
    [No Abstract]   [Full Text] [Related]  

  • 47. [Rifampicin and ethambutol combination in the treatment of pulmonary tuberculosis. Partial results].
    Ennes Filho E; Azevedo DE; Sayeg F
    Rev Bras Med; 1971 Apr; 28(4):171-9. PubMed ID: 5120854
    [No Abstract]   [Full Text] [Related]  

  • 48. Rifampicin in the treatment of chronic pulmonary tuberculosis. Investigations on clinical activity and side effects.
    Pickroth G; Anschel R; Kalich R; Kandt D
    Acta Tuberc Pneumol Belg; 1969; 60(3):513-8. PubMed ID: 5371676
    [No Abstract]   [Full Text] [Related]  

  • 49. [Maximum therapeutic efficiency of a guternary antitubercular preparation. (Streptomycin-ethambutol-rifampicin-isoniazid)].
    Almansa de Cara S
    Rev Clin Esp; 1972 May; 125(4):353-6. PubMed ID: 5080180
    [No Abstract]   [Full Text] [Related]  

  • 50. [Treatment of intractable pulmonary tuberculosis: place of capreomycin in therapeutic programs with rifampicin and ethambutol].
    Oury M; Tuchais E; Norval C; Carbonnelle B; Leroux MF; Corre C; Parvery F
    Rev Tuberc Pneumol (Paris); 1970 Jun; 34(4):519-30. PubMed ID: 5510321
    [No Abstract]   [Full Text] [Related]  

  • 51. [Preliminary report on the results of retreatment with rifomycin AMP and ethambutol].
    Ibarra JP; Costa de Mello B; Mazza de Pratto N
    Hoja Tisiol; 1969; 26(1):113-26. PubMed ID: 5401724
    [No Abstract]   [Full Text] [Related]  

  • 52. [Team-controlled study the effectiveness of chemotherapy with outpatients with fibrous-cavitary tuberculosis].
    Margulis NIu; Korotaev GA; Golubeva VN; Iusman ZI; Roslik SM
    Probl Tuberk; 1984 Jun; (6):6-11. PubMed ID: 6382251
    [No Abstract]   [Full Text] [Related]  

  • 53. [Place of ethambutol associated with isoniazid or with rifampicin in the treatment of pulmonary tuberculosis].
    Lesobre R; Frey N
    Therapeutique; 1971 Apr; 47(4):387-90. PubMed ID: 5564051
    [No Abstract]   [Full Text] [Related]  

  • 54. [New antitubercular preparations rifampicin and ethambutol].
    Utkin VV; Poleshchuk AK; Zankisova IG; Mkrtchian SV; Krylova NP
    Klin Med (Mosk); 1971 Apr; 49(4):39-45. PubMed ID: 5561605
    [No Abstract]   [Full Text] [Related]  

  • 55. [Rifampicin and ethanbutol in daily and intermittent treatment of chronic advanced cavernous pulmonary tuberculosis resistant to many drugs. Preliminary communication. Early results].
    Zierski M; Bek E; Kucharska A; Graczyk J; Bukalska Z
    Gruzlica; 1973 Nov; 41(11):1129-37. PubMed ID: 4765793
    [No Abstract]   [Full Text] [Related]  

  • 56. Clinical effect of rifampicin-ethambutol isoniazid on untreated pulmonary tuberculosis.
    Konno K; Oizumi K; Yamada S; Ogata K; Sato M
    Sci Rep Res Inst Tohoku Univ Med; 1972 Sep; 19(2):68-72. PubMed ID: 4649624
    [No Abstract]   [Full Text] [Related]  

  • 57. Rifampin in the treatment of pulmonary tuberculosis.
    Hyde L
    Calif Med; 1972 Dec; 117(6):18-21. PubMed ID: 4635395
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [New aspects of medical therapy of pulmonary tuberculosis].
    Brouet G
    Acquis Med Recent; 1970; ():31-42. PubMed ID: 5526179
    [No Abstract]   [Full Text] [Related]  

  • 59. [Results of initial treatment of pulmonary tuberculosis using ethambutol, isonicotinic acid hydrazide and rifampicin].
    Kesztele V; Niederkofler J
    Wien Med Wochenschr; 1970 Jun; 120(25):473-5. PubMed ID: 5518004
    [No Abstract]   [Full Text] [Related]  

  • 60. [3 cases of treatment of advanced tuberculosis with multiresistant bacilli by combined rifomycin-ethambutol].
    Hennebert A
    Acta Tuberc Pneumol Belg; 1969; 60(3):507-12. PubMed ID: 5371675
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.